1
Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)
Condition(s):Cerebrotendinous XanthomatosesLast Updated:August 12, 2022Completed
Xanthomatosis: 14 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
A Study on the Prevalence of Mutation of Cerebrotendinous Xanthomatosis (CTX)
Condition(s):Xanthomatosis, CerebrotendinousLast Updated:April 1, 2021Unknown status
3
Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis
Condition(s):Cerebrotendinous Xanthomatosis (CTX)Last Updated:June 7, 2012Unknown status
4
Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Condition(s):Cerebrotendinous Xanthomatosis (CTX)Last Updated:November 9, 2018Unknown status
5
An Observational Study for Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease
Condition(s):CTX – Cerebrotendinous XanthomatosisLast Updated:June 15, 2022Terminated
6
Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis
Condition(s):Cerebrotendinous XanthomatosisLast Updated:June 24, 2005Unknown status
7
The Prevalence of CTX Disorder in Juvenile Cataract Cases in Turkey
Condition(s):Cerebrotendinous XanthomatosisLast Updated:March 29, 2021Unknown status
8
Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)
Condition(s):CTXLast Updated:March 2, 2023Recruiting
9
Cholestanol in Humans
Condition(s):Cerebrotendinous XanthomatosisLast Updated:October 14, 2013Withdrawn
10
Atorvastatin Therapy on Xanthoma in Alagille Syndrome
Condition(s):Alagille Syndrome; Atorvastatin; XanthomaLast Updated:February 8, 2023Recruiting